What Is CRE? The “Superbug” at the Center of the Scope Infections

Read almost any headline about the Olympus duodenoscope cases and you will hit the word “superbug.” It sounds like tabloid shorthand, but it points to a precise and dangerous reality. In the scope outbreaks that put these devices on the national radar — including the 2015 outbreak at UCLA’s Ronald Reagan Medical Center — the organism doing the harm was usually CRE: carbapenem-resistant Enterobacterales. This article explains, in plain English, what CRE is, why the U.S. Centers for Disease Control and Prevention treats it as one of the most serious antibiotic-resistance threats in the country, how a reusable scope can pass it from one patient to the next, and why the exact organism recorded in a patient’s chart can matter to a scope infection case.

What Is CRE, in Plain English?

CRE stands for carbapenem-resistant Enterobacterales. Enterobacterales are a large family of ordinary bacteria that live in the human gut — names most people have heard, like E. coli, and others like Klebsiella pneumoniae. On their own, many of these germs are harmless residents of the intestine. They become a “superbug” when they pick up resistance to carbapenems, a class of powerful antibiotics that doctors hold in reserve as a last line of defense. When a common gut organism becomes resistant to the drug of last resort, an ordinary infection can turn into one that few — or no — antibiotics can cure.

That is why the CDC classifies CRE as an “urgent threat,” its highest category of antibiotic-resistance danger, alongside a short list of organisms the agency considers the most pressing. In its national threat assessment, the CDC estimated roughly 13,100 CRE cases among hospitalized patients and about 1,100 deaths in a single year, and the agency has warned that these infections contribute to death in a large share of the patients who develop them. CRE spreads mainly in healthcare settings — hospitals, long-term care facilities, and, importantly here, on contaminated medical equipment that moves from patient to patient.

Why “Superbug” Is More Than a Headline Word

The everyday meaning of “superbug” is a germ that shrugs off the antibiotics meant to kill it. For CRE, that description is close to literal. Some strains produce enzymes — carbapenemases such as KPC and NDM — that chemically disable the antibiotics before they can work. The CDC has flagged a sharp rise in NDM-producing CRE in recent years, and NDM strains are especially difficult because the medicines that treat most other CRE often do not work against them. For a patient, the practical consequence is that a bloodstream infection or an infection of the bile ducts can outrun the treatments available, leaving physicians with very few options.

This is what separates a scope-related CRE infection from an ordinary post-procedure fever. The danger is not only that a person got sick after an endoscopy — it is that the organism they were exposed to is one medicine may not be able to stop. Understanding how the illness typically unfolds is its own subject; our guide to the scope infection symptom timeline walks through why the connection between a procedure and a later illness is so often missed.

How Does a Duodenoscope Spread CRE?

A duodenoscope is a flexible, reusable instrument threaded through the mouth and stomach into the top of the small intestine to reach the bile and pancreatic ducts during a procedure called ERCP. Because it travels through the gut, it naturally comes into contact with the very bacteria — CRE among them — that live there. The scope is then cleaned and reused on the next patient. The whole safety of that model depends on one assumption: that reprocessing removes everything the last patient left behind.

The evidence says that assumption does not always hold. At the tip of the duodenoscope is a tiny hinged part called the elevator mechanism, along with narrow internal channels, and both are notoriously hard to clean. The FDA’s own post-market surveillance found that roughly 1 in 20 duodenoscopes still tested positive for contamination after reprocessing — even when hospitals followed the cleaning instructions correctly. When drug-resistant bacteria survive on a scope, the device itself becomes the bridge: the same instrument can deliver CRE straight into the next patient’s biliary system. That is the mechanism behind “patient-to-patient transmission,” and it is why a single contaminated duodenoscope has been able to sicken many people traced to one machine.

The Outbreak That Made CRE a Household Fear

In February 2015, UCLA’s Ronald Reagan Medical Center disclosed that a CRE outbreak had been linked to contaminated Olympus duodenoscopes. Two patients died, and the hospital notified roughly 179 others that they may have been exposed. An internal review found that the bacteria remained on the scopes even after staff followed the manufacturer’s cleaning protocol — the organism was effectively embedded in a device that was supposed to be clean. The scope model involved, the Olympus TJF-Q180V, later became the subject of an FDA-ordered recall and redesign.

UCLA was the case that reached the public, but it was not isolated. A 2016 U.S. Senate investigation concluded that contaminated duodenoscopes were linked to at least 25 separate outbreaks that sickened patients around the world between 2012 and 2015, and earlier peer-reviewed reports had already tied duodenoscopes to NDM-producing, carbapenem-resistant organisms at U.S. hospitals. We keep a running, plain-English reference of the documented Olympus scope outbreaks at U.S. hospitals for patients trying to place their own experience in context.

CRE Is Not the Only Organism Scopes Have Spread

CRE is the headline superbug, but contaminated scopes have transmitted a range of dangerous bacteria. Investigators have documented outbreaks involving Pseudomonas aeruginosa, drug-resistant Klebsiella pneumoniae, E. coli, and vancomycin-resistant Enterococcus (VRE), among others. What these organisms share is a tendency to cause serious infection when they are introduced where they do not belong — the bloodstream, the biliary tract — and a resistance profile that makes them hard to treat. The common thread is not one particular germ; it is a device that can carry whatever survived on it into the next person. For most patients, the illness first shows up as the sepsis and bloodstream infections that can follow an ERCP.

Why the Specific Organism Matters to a Case

Scope infection claims generally move on two theories that can run together: product liability against the device manufacturer for an instrument alleged to be defective, and negligence against a hospital for how it cleaned and tracked its equipment. In both, the identity of the organism is a piece of evidence. When a patient develops an infection with an uncommon, drug-resistant germ like CRE shortly after an endoscopy — and the same organism is later found on a scope or in other patients from the same unit — that convergence is precisely what public-health investigators and lawyers look at. Our overview of hospital reprocessing negligence explains how those responsibilities are divided.

None of that, standing alone, proves an individual claim. A named organism is a lead, not a verdict. What decides a particular case is specific and personal: the patient’s own culture and sensitivity results, which scope model and reprocessing equipment were used, whether the facility logged a cluster of similar infections, and how the timeline in the medical record lines up. That is why these cases are built one chart at a time.

A Trial Lawyer’s Read

“When I hear that a client grew a drug-resistant organism after a routine scope procedure, that word — resistant — is the first thing I focus on,” says Alex Alvarez, Managing Partner of The Alvarez Law Firm and a Board Certified Civil Trial Lawyer. “Ordinary gut bacteria don’t usually end up in someone’s bloodstream by accident. When they do, and they’re resistant to the antibiotics we save for emergencies, that’s a signal to go find out exactly what device touched that patient and what the hospital’s own records show.”

The medical detail is what turns a superbug diagnosis into a fact pattern. “The culture report is where I start,” notes Herb Borroto, M.D., J.D., the firm’s Medical-Legal Expert, who holds both a medical degree and a law degree. “I want the organism, the resistance pattern, and the date it was collected, and then I lay that against the procedure date and the reprocessing logs. If a carbapenem-resistant organism shows up days after an ERCP, and the facility had other patients with the same bug, the record is telling a story. My job is to read whether the chart supports that story or rules it out — and that’s a question the documents can actually answer.”

What to Do Now

If you or a loved one developed a serious infection — sepsis, a bloodstream infection, or a drug-resistant “superbug” such as CRE — after an ERCP, colonoscopy, or other procedure using a reusable scope, the specific organism in the records is one reason to have the facts reviewed while those records still exist. Culture results, device-tracking logs, and reprocessing files are exactly the materials that get archived or discarded on routine retention schedules, and knowing what to look for — starting with the signs an infection was caused by a scope — can make the difference between a preserved case and a lost one.

A short, no-obligation review can tell you whether your situation fits the pattern and whether a filing deadline may be approaching. We represent patients nationwide. Free case review. No Fees Unless We Recover Money for You.

Frequently Asked Questions

What does CRE stand for, and why is it called a superbug?

CRE stands for carbapenem-resistant Enterobacterales — a family of common gut bacteria, such as certain strains of Klebsiella pneumoniae and E. coli, that have become resistant to carbapenems, the antibiotics doctors rely on as a last-line treatment. Because these organisms can resist all or nearly all available antibiotics, the CDC calls them a superbug and classifies CRE as an urgent public-health threat, its highest tier.

How does a duodenoscope spread CRE from one patient to another?

A duodenoscope is a reusable device that is passed into the intestine, so it routinely picks up gut bacteria, including CRE, from one patient. The scope’s tiny hinged elevator mechanism and narrow internal channels are difficult to clean, and the FDA has found that scopes can remain contaminated even after hospitals follow the cleaning instructions correctly. If bacteria survive that reprocessing, the same scope can carry them into the next patient — which is how a single contaminated duodenoscope has caused patient-to-patient outbreaks.

How dangerous is a CRE infection?

CRE infections are among the most serious healthcare-associated infections because so few antibiotics work against them. The CDC has reported that CRE contribute to death in a large share of patients who develop bloodstream infections with these organisms, and it estimated roughly 13,100 cases and about 1,100 deaths among hospitalized U.S. patients in a single year. The danger for any individual depends on the organism, the site of infection, and the patient’s overall health.

Why does the specific bacteria matter to a scope infection lawsuit?

The organism cultured from a patient is one of the threads that can connect an illness back to a contaminated scope. When an unusual, drug-resistant organism such as CRE appears after an ERCP or other endoscopy, and the same organism is found on the device or in other patients from the same facility, that pattern is exactly what public-health investigators and lawyers examine. It does not prove any individual claim by itself; what decides a case is the patient’s own culture results, the device and reprocessing records, and the timeline in the chart.

Sources

• U.S. Centers for Disease Control and Prevention — “About Carbapenem-resistant Enterobacterales (CRE)” (what CRE is, how it spreads in healthcare settings, and why it is difficult to treat). cdc.gov
• U.S. Centers for Disease Control and Prevention — “Antibiotic Resistance Threats in the United States, 2019” (CRE classified as an urgent threat; estimated cases and deaths among hospitalized patients). cdc.gov
• U.S. Food & Drug Administration — “Infections Associated with Reprocessed Duodenoscopes” (post-market surveillance sampling and contamination-after-reprocessing findings for reusable duodenoscopes). fda.gov
• U.S. Senate Committee on Health, Education, Labor and Pensions (Minority Staff Report) — “Preventable Tragedies: Superbugs and How Ineffective Monitoring of Medical Device Safety Fails Patients” (January 2016; duodenoscopes linked to at least 25 outbreaks, 2012–2015). help.senate.gov
• Epstein L, et al. “New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Escherichia coli Associated with Exposure to Duodenoscopes.” JAMA, 2014. jamanetwork.com

This article is for general informational purposes only and is not legal or medical advice. It summarizes public health information and general infection concepts as of the publication date; medical guidance and regulatory status can change, and this article does not describe the outcome of any client’s case. The presence of a particular organism is evidence to be evaluated, not proof of any individual’s claim. Nothing here creates an attorney-client relationship, and no result is promised or implied. Past results do not guarantee future outcomes. Deadlines and legal standards vary by state and by the facts of each case. If you believe you may have a claim, consult a licensed attorney promptly.